Status:
COMPLETED
Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Hepatitis C
Eligibility:
All Genders
19-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to obtain single dose safety and pharmacokinetic (PK) data of IDX184 in humans. No formal hypotheses are to be tested in this study.
Eligibility Criteria
Inclusion
- Participants are in general good health.
- All participants of childbearing potential must have agreed to use a consistent form of an acceptable double-barrier method of birth control
Exclusion
- Participant is pregnant or breastfeeding.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00730431
Start Date
July 1 2008
End Date
October 1 2008
Last Update
April 23 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.